Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from VRTX

S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

S&P 500 giant Vertex and Cheniere Energy, the largest U.S. liquefied natural gas producer, are setting up bullishly in the bear market.

Investors Business Daily

2 No-Brainer Biotech Stocks to Buy Right Now and 1 to Sell

The biotech industry is set to benefit from continued investments in breakthrough developments and federal support. Against this backdrop, fundamentally strong biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) could be solid buys. However, Relmada Therapeutics (RLMD) might be best avoided considering its weak fundamentals. Read on….

StockNews.com

Dow Jones Futures Rise On U.K. U-Turn Ahead Of CPI Inflation Report

Stocks were quiet Wednesday, as investors avoided rallying into the CPI inflation report. EV plays Albemarle and Aehr Test Systems dived.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures Rise, Bond Yields In Flux With Inflation Reports Due

Futures pared gains as the 10-year Treasury yield in flux with big inflation reports due. The S&P 500 is at bear market lows.

Investors Business Daily

2 Top Biotech Stocks to Buy for the Long Haul and 1 to Sell

Government initiatives to expand domestic biotech production and research and rising private investments in advancing technologies are expected to boost the industry’s prospects. While we believe biotech stocks Vertex Pharmaceuticals (VRTX) and Biogen (BIIB) could be ideal investments for the long run, fundamentally weak Timber Pharmaceuticals (TMBR) might be best…

StockNews.com

IBD Stock Of The Day Vertex Pharma: Why Its 'Sandbox' Approach Is Unusual In Biotech

Vertex Pharmaceuticals is the IBD Stock Of The Day as VRTX stock climbs higher on expectations for its next act in gene editing.

Investors Business Daily

3 Stocks to Ride the Bear Market Rally

Stocks could be embarking on another bear market rally despite a plethora of challenges. One factor is we are entering a seasonally bullish period of the year. Another is the bullish technical setup following the undercut and recovery of the mid-June lows. 3 stocks that investors should consider buying to…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Futures Fall: Market Rally At Pivotal Point; Tesla, Enphase Skid

The stock market rally showed resilience, as the Dow Jones slashed early losses, but is at a pivotal point. Tesla fell while Enphase plunged.

Investors Business Daily

Vertex Among 25 Market Leaders On The IBD Breakout Stocks Index

As the market shows signs of a rebound, Vertex, Enphase and Shockwave Medical are among 25 stocks to watch.

Investors Business Daily

Vertex Among 9 Stocks To Watch In Struggling Market

As the market indexes work through a downturn, Vertex is among nine stocks to watch showing relative strength.

Investors Business Daily

Vertex Stock Flashes Buy Signal; Gene-Editing Play Leads 5 Resilient Stocks In Bear Market

Vertex Pharmaceuicals flashed a buy signal last week on positive gene-editing news. It's one of several resilient stocks to watch in the bear market.

Investors Business Daily

Vertex Nears Buy, Joins Crispr To Advance A Gene-Editing First

As biotech leaders Vertex and Crispr shoot for a gene-editing first, VRTX stock takes aim at a new breakout.

Investors Business Daily

Dow Jones Futures Fall As Treasury Yields Rebound; Eli Lilly Leads 7 Bullish Stocks

Dow Jones futures fell as Treasury yields rebounded, signaling Wednesday's rally may be short-lived. Eli Lilly leads some bullish stocks.

Investors Business Daily

Vertex, IBD Stock Of The Day, Expands Its Drugmaking Portfolio

Vertex Pharmaceuticals is the IBD Stock of the Day as the global biotech company climbs above its 50-day moving average.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Neurocrine Leads 5 Stocks To Watch In Sickly Market

Neurocrine Biosciences leads five medical stocks near key support levels as the health care sector shows resilience in a sickly market.

StockNews.com

Minerva Neurosciences up More Than 100% This Week, but Is It a Better Pick Than Vertex Pharma?

Minerva Neurosciences (NERV) and Vertex Pharmaceuticals (VRTX) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the industry. Since NERV has gained more than 100% this week, is it a better investment than VRTX? Read more to find out….

Investors Business Daily

Dow Jones Futures Signal Market Rally Pullback, Bitcoin Tumbles; BBBY Stock Dives In Reversion To The Meme

Dow Jones futures fell as the market rally pulls back with Bitcoin tumbling. BBBY stock dived in a "reversion to the meme."

StockNews.com

5 Biotech Stocks in the Buy Zone This Week

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

This Biotech Breakout Star is Our Growth Stock of the Week

Vertex Pharmaceuticals (VRTX) is a high-quality biotech stock that is quite cheap with impressive growth prospects. Read on to find out why it’s our growth stock of the week….

Investors Business Daily

VRTX Stock Provides Multiple Swing Trading Lessons

Just because a stock doesn't work the first time doesn't mean you shouldn't try again.

StockNews.com

3 Stocks to Buy With Rising Recession Risk, Increasing Geopolitical Tensions

Despite the bear market rally, the market is facing serious risks due to rising recession risk and increasing geopolitical tensions. Here are 3 defensive picks to help investors outperform in this tricky environment: Lockheed Martin (LMT), Vertex Pharmaceuticals (VRTX), and Elevance Health (ELVH).

Investors Business Daily

Bull Call Spread On Vertex Pharmaceuticals Taps Into Stock's Newfound Strength

Vertex Pharmaceuticals is showing is showing green check marks across the board, and today we will look at a bullish option strategy.

Investors Business Daily

Vertex Makes Bullish Move On Earnings, Leading 5 Stocks To Watch

Vertex Pharmaceuticals made a bullish move on earnings amid a confirmed market rally, leading five stocks to watch this week.

Investors Business Daily

Dow Jones Futures: Jobs Report Tests 'Soft Landing' Market Rally; Tesla Stock Split Approved

The indexes were quiet before the July jobs report tests the Fed's soft landing. Tesla shareholders OK'd a 3-for-1 stock split.

Investors Business Daily

Vertex Raises 2022 Outlook As Powerhouse Trikafta Drives Quarterly Beat

Vertex Pharmaceuticals said its triple-regimen in cystic fibrosis is gaining new users abroad. VRTX stock jumped Friday.

1 … 3 4 5 6

People

Elon Musk

17,681 stories

Dipanjan BanchurSince

Jaimini DesaiJaimini Desai

59 stories

Brian Abrahams

56 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.